Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
0.083CHF
1.31 MCHF
93.97 MCHF
7.36 M
About COSMO PHARM N
Sector
CEO
Alessandro Della Chà
Headquarters
Dublin
Website
Founded
2016
ISIN
NL0011832936
FIGI
BBG00CWX1FT9
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of C43 is 71.637 CHF — it has increased by 2.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange COSMO PHARMA N.V. stocks are traded under the ticker C43.
COSMO PHARMA N.V. is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
C43 stock is 2.24% volatile and has beta coefficient of 1.57. Check out the list of the most volatile stocks — is COSMO PHARMA N.V. there?
Yes, you can track COSMO PHARMA N.V. financials in yearly and quarterly reports right on TradingView.
C43 net income for the last quarter is −133.11 K CHF, while the quarter before that showed 1.46 M CHF of net income which accounts for −109.09% change. Track more COSMO PHARMA N.V. financial stats to get the full picture.
Today COSMO PHARMA N.V. has the market capitalization of 1.15 B, it has increased by 7.87% over the last week.
Yes, C43 dividends are paid annually. The last dividend per share was 1.02 CHF. As of today, Dividend Yield (TTM)% is 1.43%. Tracking COSMO PHARMA N.V. dividends might help you take more informed decisions.
Like other stocks, C43 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COSMO PHARMA N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COSMO PHARMA N.V. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COSMO PHARMA N.V. stock shows the neutral signal. See more of COSMO PHARMA N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on COSMO PHARMA N.V. future price: according to them, C43 price has a max estimate of 109.78 CHF and a min estimate of 78.81 CHF. Read a more detailed COSMO PHARMA N.V. forecast: see what analysts think of COSMO PHARMA N.V. and suggest that you do with its stocks.